0001209191-23-049792.txt : 20230918
0001209191-23-049792.hdr.sgml : 20230918
20230918173457
ACCESSION NUMBER: 0001209191-23-049792
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230914
FILED AS OF DATE: 20230918
DATE AS OF CHANGE: 20230918
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Loewen Andrea
CENTRAL INDEX KEY: 0001591100
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37785
FILM NUMBER: 231261977
MAIL ADDRESS:
STREET 1: C/O VITAL THERAPIES, INC.
STREET 2: 15010 AVENUE OF SCIENCE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92128
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REATA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001358762
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113651945
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5320 LEGACY DRIVE
CITY: PLANO
STATE: TX
ZIP: 75024
BUSINESS PHONE: 972-865-2219
MAIL ADDRESS:
STREET 1: 5320 LEGACY DRIVE
CITY: PLANO
STATE: TX
ZIP: 75024
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-09-14
0
0001358762
REATA PHARMACEUTICALS INC
RETA
0001591100
Loewen Andrea
5320 LEGACY DRIVE
PLANO
TX
75024
0
1
0
0
SVP, Global Regulatory Affairs
0
Class A common stock
2023-09-14
4
S
0
3175
172.0254
D
28416
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $172.02 to $172.035. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
/s/ Tracy Herson, attorney-in-fact
2023-09-18